Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 12, 2002, Pages 1350-1356

  Kamala, F ^a   Boo, N Y ^a   Cheah, F C ^a   Birinder, K ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Catheter blockage; Heparin; Peripherally inserted central catheters

Indexed keywords

HEPARIN;

ARTICLE; BACTEREMIA; BLOOD SAMPLING; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPARINIZATION; HUMAN; HYPERBILIRUBINEMIA; HYPERTRIGLYCERIDEMIA; INFANT NUTRITION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TOTAL PARENTERAL NUTRITION;

EID: 0036983745     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2002.tb02833.x     Document Type: Article

References (24)

1. Sketch MH, Cale M, Mohiddin SM, Booth RW. Use of percutaneously inserted venous catheters in coronary care units. Chest 1972; 62: 684-9
2. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect 2001; 48: 108-16
3. Moclair A, Bates I. The efficacy of heparin in maintaining peripheral infusion in neonates. Eur J Pediatr 1995; 154: 567-70
4. Alpan G, Eyal F, Springer C, et al. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. Pediatrics 1984; 74: 375-8
5. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomized controlled trials. Br Med J 1998; 316: 969-75
6. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med 1996; 24: 1482-9
7. Tanner WA, Delaney PV, Hennessy TP. The influence of heparin on intravenous infusion: a prospective study. Br J Surg 1980; 67: 311-2
8. Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Neonatal Collaborative Review, 2001
9. Broderson R. Binding of bilirubin to albumin. CRC Crit Rev Clin Lab Sci 1980; 11: 305-9
10. Wiegand UW, Soda DM, Levy G. Effect of heparin on bilirubin clearance in rats: pharmacokinetic consequences of extensive hepatic extraction of plasma protein binding inhibitors. J Pharm Sci 1980; 69: 1228-30
11. Berkow SE, Spear ML, Stahl GE, et al. Total parenteral nutrition with Intralipid in premature infants receiving TPN with heparin: effect on plasma lipolytic enzyme, lipid and glucose. J Pediatr Gastroenterol Nutr 1987; 6: 581-8
12. Roth B, Ekelund M, Fan BG, Ekstrom U, Nillson-Ehle P. Effects of heparin and low molecular weight heparin on lipid transport during parenteral feeding in the rat. Acta Anaes Scand 1996; 40: 102-11
13. Spear ML, Stahl GE, Hamosh M, et al. Effect of heparin dose and infusion rate on lipid clearance and bilirubin binding in premature infants receiving intravenous fat emulsions. J Pediatr 1988; 112: 94-8
14. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993; 10: 229-32
15. Chang GY, Lueder FL, DiMichelle DM, et al. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr 1997; 131: 362-6
16. Warkentin TE, Levine MN, Hirsch J, et al. Heparin-induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5
17. Lesko SM, Mitchell AA, Epstein MF, et al. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med 1986; 314: 1156-60
18. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol 1995; 15: 185-91
19. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-7
20. Papille LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 grams. J Pediatr 1978; 92: 529-34
21. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72
22. Cockington RA. A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. J Pediatr 1979; 95: 281-5
23. Kropect A, Huebner J, Frank U, Lemmen S, Hirt U, Daschner FD. In vitro activity of sodium bisulfite and heparin against staphylococci: new strategies in the treatment of catheter-related infection. J Infect Dis 1993; 168: 235-7
24. Elliott TS, Curran A. Effect of heparin and chlorbutol on bacterial colonisation of intravascular cannulae in an in vitro model. J Hosp Infect 1989; 14: 193-200